medigraphic.com
ISSN 1561-2945 (Print)

2013, Number 1

<< Back Next >>

Revista Cubana de Cirugía 2013; 52 (1)

Dilated myocardiopathy and pheochromocytoma

González GJL, Menéndez NJ, Escarpanter JC, Lazo AA

Language: Spanish
References: 12
Page:
PDF size: 155.49 Kb.


ABSTRACT

Pheochromocytoma, a low incidence tumor of benign behavior in most of cases, can cause extensive cardiovascular manifestations. These manifestations on the myocardium can have deep consequences since they may lead to dilated myocardiopathy with severe heart failure. The excision of tumor may be the curative solution for 90 % of cases but the perioperative management is very complex. This is the case of a young patient who carries pheochromocytoma and after a long-acting catecholemine-based treatment, he developed dilated myocardiopathy, and the medical criterion was that he required heart transplantation. The adrenal surgery was successfully healing in our patient.


REFERENCES

  1. Kohl BA, Schwartz S. Cirugía en el paciente con disfunción endocrina. Anesthesiology Clinics. 27(2009):687-703. Disponible en: http://www.elsevier.es/sites/default/files/elsevier/pdf/503/503v27n04a13156456p df001.pdf

  2. Arteaga Hernández JL, Plaza González T, Suero Almonte S, Calzadilla García L, Ceramides, Almora Carbonel L. Feocromocitoma. Presentación de un caso. Revista de Ciencias Médicas de Pinar del Río; 15(3):2011. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1561-31942011000300019&script=sci_arttext

  3. Academia Nacional de Medicina. Consenso Nacional Inter-Sociedades para el diagnóstico y tratamiento de las neoplasias renales parenquimatosas del adulto. Rev Arg Radiol. [Revista en Internet]. 2010 [Citado el 18 de julio de 2011];74(3):15.

  4. Magalhaes AP, Pastor A, Núñez A, Cosío FG. Taquicardia ventricular como manifestación clínica inicial de feocromocitoma. Rev. Esp. Cardiol. 2007;60(4):450-1.

  5. Liao WB,Liu CF, Chiang CW. Cardiovascular manifestations of pheochromocytoma.Am J Emerg Med. 2000;18:622-5.

  6. Plouin PF, Duclos JM, Soppelsa F, Boublil G and Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab 2001;86:1480-6.

  7. Lastiri H. Clasificación de la miocardiopatías y miocardiopatía dilatada 5to Congreso Virtual de Cardiología.Setiembre de 2007. Disponible en:http://www.fac.org.ar/1/revista/05v34n3/art_orig/ar_ori02/lastiri.php

  8. Maron BJ, Towbin JA, Thiene G, Antzelevitch C,Corrado D, Arnett D, et al. Contemporary Definitions and Classification of the Cardiomyopathies: An American Heart Association Scientific Statement From the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807-16.

  9. Lenders JW, Pacak K, Walther MM. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002;287:1427-34.

  10. Pacak K, Linehan WM, Eisenhofer G. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med. 2001;134:315-29.

  11. Bravo EL. Pheochromocytoma. Current Therapy Endocrinolgy Metab. 1997;6:195- 7.

  12. Newell KA, Prinz RA, Brooks MH. Plasma catecholamine changes during excision of pheochromocytoma. Surgery. 1988;104:1064-73.




2020     |     www.medigraphic.com